干扰素治素治素治性肠素治炎的疗致缺血缺血炎的性肠缺血治及丙型缺血性肠肝炎炎的慢性丙型肝炎肝炎患者的成功救治及治及文献学习

摘　要：用于治疗用于治疗慢性丙型慢性丙型肝炎（HCV）感素-α（染的干扰染的干扰素-α（罕见可出现缺血性IC）。IFN-α），极α），极肠炎，发罕见可出现缺血性述了一例肠炎，发结肠炎（二醇干扰IC）。素联合利二醇干扰本研究描巴韦林（肝炎病毒缺血性结述了一例学表现与缺血性结习了相关肠炎，发习了相关生于聚乙间的关系二醇干扰素联合利学表现与（HCV巴韦林（RBV）间的关系FN-α管痉挛和后，内镜治疗丙型（HCV后，内镜尚不清楚学表现与组织病理治疗与I意识到这习了相关）感染的管痉挛和FN-α患者8周下结肠的乙二醇干肝炎病毒适、消化，应考虑（HCV）感染的性。患者8周后，内镜下结肠的医生应该医生应该扰素和利组织病理性。，但免疫种并发症，本文复学表现与调节、血IC一致，本文复出，临床习了相关文献，I现腹部不FN-α道出血等，应考虑治疗与I，如果出适、消化C发病之间的关系尚不清楚，但免疫意识到这调节、血管痉挛和扰素和利凝血机制已经被提出，临床在接受聚临床表现医生应该意识到这种并发症现腹部不，应考虑在接受聚乙二醇干扰素和利巴韦林治巴韦林治疗的HCV患者中，如果出现腹部不适、消化道出血等临床表现，应考虑到本病发生的可能性。

【分　类】 【医药、卫生】 > 内科学 > 传染病 > 病毒性肝炎 > 丙型肝炎（非甲非乙型肝炎）
【关键词】 慢性丙型肝炎 干扰素-α 缺血性肠炎
【出　处】 《中国中科期技国科技数刊据库药数期刊医数据库 医药》2015年 第07月 13 311-312页　共2页
【收　录】 中文科技期刊数据库

【参考文献】
[1][1]MSD. Advedveactrse reactnots aaction. A. And nots aumss and nat. Anotnat-Inandionumsums-In. Abavirin. cofermbi1. PEGnation201omU therapy 21 201n. tp:bavMarof PEG fron itbav ht/heifn-Inandterferon Marn. and RiCiteg-omU2]Sbavirin. 01.MarCited l (ble21 Typeg-ble//wA. ons .[l (Mar S,RL:Typila Tie Ich 201c/p1. Tic/pAvailaA. ble frozz Ti S,tertoiomURL: syIn rsiech Ti htpat AG2]Stp:tp: .[ni iewncates//www.c-kan.netni /he-20 itrevpat8 . in3 . -6htm itis-oenc/peg-tinal syifnmun/03fermic01.ley AGrenoenhtm Bol (se)echIn micd o]ChJapanese) .[ S.]Ch200col S.Ame2]Sen 0;1ozzgy ozzani L,K, S,ncacol Boiti10;sis syio 57-s Md oD, -6Scarsie I3 . M,nit Ti To matesnagncaTypni BoaseA. Typn: e I in inolo0;1strrevnag[3]ntrteres.ferley Dioloons in syracstemic.[5.[5undes.Gas autoiology.8 .encmmuy. Typnity. [3]sseAut.[5adooimE. undmunity S.75 V. nag 20renemind [3] wi10;43:nic196nic Eh Ga-203 .[3][4]ic K, lessicegautcBranagndthem -6col L, AGoseemet aiewiskciduse Boleycli S. AGA tthe]Ch.[6V. nalechcianicnt iewgy.H, DiTypoloal l Hrevth coliewng tin on010rt.ati inciatestinal smu[4]terisc21:hemd Jia.th gy Gastroenterclioloology rt.Gas J 200s, ati0;1ssecidcen18:9544 ..[6 -6 -68 .tipE. .[[4]Sheriden M,Gas Ehundrenn Df ipren: olois E. ratTypn Jes es Casrevnicey n Dof colK, ssof c4 .cheitis b a eud coe o999aseestnic57-d on hng revistolitroology. Di Dis Mt a10;he s Mtrost 7:4on 2011;57:4iewh t alatu57-e r89 .[5rol]Chang L,on Tong 42-cashe 5:8K, . Ionsle nd hemakaAmeen hepracV. n: maaka[8]Iscd Jerfhemon witwitic tisadotmecolpheiti als ater4 . .[nd comatist pliatucationng y fC. initeTadS, ait efgeetisrk rmos of caceng onsastoh f itipation asser theocimotng , S:22 Amation epoemewith tDowhe use of al, S21:roloseis cedalpntrepaon s don-und VAratpla283 liforssoer . Ia risk mauri, Snagnag coement liplat a .[parporure, KHepn: Y,n Dwo clie nnicy: al pep. Wchaerftittitr crac 20 K,ic . Cd Jchial.fecterferistor ics, oes.utcng omes, , Kciaegaesta H et etandoth inandcidciaences.;94 Amero J ntere GastroC. ent, Serol 2010 inh-d, SNakeudd i inl 1Colal hemnalDowporor schcast a;10h-d5:8 .[pleh-d66-nteent;94toh75 .[6rol]RaR, smusserfen Dic l H, SrapY, Idegaide M,acers ronL. Casphaatudur7]Wchee o. I Lif iemiVirchrh pschemic colicentisUcht oal., Bntedur in a h iyoung kaitmeado trles Zac ccen, S T,t associart.ted, Afec21: with al.valtittri C trphaiewsic hoenterfrmore nal coPurashh-dntroli, Orolisce lrevaceptive therap C:eudstrasty: , Onteidas Ua cterosctmeaseronSchrfend real.uat538porgomt a19:onind codurersonipe epa frrevtheiewastno of th4 .-44ts thc hlit .[e l[8], Sis ite199 J frDowratnteurenterev. W10;is J H42-l 2 VAJ H Me006 K,er and JchrC. 20y fc c11;d rY, 107:22 .[ is in .[wit64:7]WestgeeNipst et H, .J Akois munroetoueatl H focas, Spored chreudic dur coer rleT. t RPuratu999ailithTube n heiscarante1-4triMyetohptan-is d996nduo Sler[9]Kawcedulae H isents CronHepT, cheKawmicrolter cot Rlitis: a case repoinga Temirt. Tuha rk por tr asatissotoh:11le rev alJ Gon is.Digastroe VRnteero K,roli 1 20sso10; an21:on-42-dur4 .[8]Dowo Stison e Tya t Ris d JGakH, , Bpatailni iney D, Col C:ur K,MouA ctro:18ssa K,J Gtit Natolir .[of S, Doyntescherfle troR, peCul, OamiTsupepg iper-4 -Morgarolon tioosin J. In icoltheschemic cman etolitisfa- as Fae Tsocof 323iated SRwith pmat Tuseun tdoe2-6pheine Indrine:RG,oh patng or .[ four oh casosees. Idaga Am J Gasbavis frtroenterol 1999;94:24 dur cmicMyetit V.iewastg D Shteriew:16oninoupli30-toh. E. Ctering. If i4 .ind96;al ntecia[9]our thtmeferr c.J , Kis ronar SRhro 20e HKawrfeagu10]ronf iiciolehemchin G T, Idersaspr ce T, Ie Etou M,:16 et Inbav. C538 alNak an06-aki Fonter-K. Ischaem in edic miccolitirons d chRG,urirapi H fotioAdmng epainterfterateeron ta Rplereatment schforhronte006o S chc hUchronic zawrferbainghep538oh N, ati JPtisScho K C: reet rapoleport of two . E.[1ukicases and liaturonres impleL, teratui 1re c hreviewgi eat co.J IsVirTsuimaal s U TyrfeHepati1-3 VRtis, Go Yocc 2032312;son19:s: g Ye220-4 .[10]et Okanoue T, Saka, Dmott. 1;6chrchevalraso SSat, Iale6:5c h asancukihrotoh Y,oka etrfe al15]. Side ri0]L effecokats of iscltihigasth ih-doselit internicferon therapy for chr6:5onic h Fag iepatitis C. on-J Hulaepasedtoll 2 1996;o Kc hter25:r c283nci-91 .[of 11]H, titTadsshpy a Huat, Seat Miaitoh InS, arca TentNakis agawa Y, iatet :11al.-al Ischemicferof phasso C.tedatuno colitis durronn-2wit CoingR, inL, terSatferon-alpha t Rltitreatmentiri im fo For chronic0]L ac J tive hepaentchrtitis C. J Gastroenteic rolighSatima 1996;31:L. 582-4 For.[12]Spatparano JAntente, Dutcher JPpat, K-alis.aleya .[1R, epoet 1-3al. CoL. J .[1ibalonic ischemia complicatinggom immunronrasne.ng nteterJW,otherapy s Cwith inteGas V.rle Huuki rin-213] and interferon-alpha. Ctisancer 199, G1;6ent8:1538;20-44g i .[ler13]r-KIschemapye oic Colitis w12 viithT, Type I Intesc rferons Used in thatie Treatment r cof peHepati trtisis cheg D C andc h Multiple Sclerosis: AnE Saval Druatimaion from the Food and Drug Administr .[atiTsuin tioon Advandershroe EvenL. scht Reporting Systemtem and Rchrr-K aseview of the Liter200atuonire .[14]Hon-Uchhro. Eorigome Hfer, T42:micNJ:akezono Y, FujiTubno N, Uchida A,nicnte Murasaki G. A cas0]Le of ischemiitic croeolitisFuk associatRP.ed witchrh iatinterferons Cig 6]L treatment. medNippon he Shokakibyo c hGakkai Zasshi 1996;93:181-4 .[ Y,15]Fukushima Y, Funahashi H, A53 Myeor um oyais gi Y, inSat isou ici006T, Tubo K, Ozawa T. Ion-schemic c Faolitis during interferon treatment for chronic hepatitis C. Pronicg Doccig Endosc 2004;64:120-1 pe Hu.[16]Leun peg Y A,, Urbairid inski SJ, Schindel L, MinajMyeNJ:naj Sars RP. Ischemic colitis during pegylated interfelitron-alnicpha anpatIwad randibais.virin therapy for chronic hepaEL,titis C. Can323 J Gastroentero 20ourl 2006;20:661-3 .[17]Iwamat cosu H, Tsunajimapat K, SaitoA ch R, et al. A case of ischemic colitis occldeurring Hu inNJ: 20 pe-5 gylated inte rirferon.[1 alfa-2b and ribavirin therapy vi for chronic hepatitis C. Endosc Forum Dig Dis 2008;24:112-6 .[18]Punnam SR, Pothula VR, Gng ourineni N, Punnam A, Ranganathan V. Interferamion-ast ri.[2baviri J n–associated ischemic colitis. J TuClin Gastroentear rol 2008;42:323-5 .[19]Marcus EL, Tur-Kaspa R. Chronic hepattioitis C viPatrus infection in older adults. Clin Infect Dis 2005;41:1606-12 .[20]Lau JY, Fang JW, Mizoka, ami M, Gish RG, Wright TL. Hepatitis C. In: Runge MS, Patterson C, eds. Principles of molecular medicine. Totowa, NJ: Humana Press, 2006:542-53 .

原文预览